Malin value grows 9% in first six months of 2021 Life science investment company, Malin, has said its value grew 9% in the first six months of the year. Business • 26 Aug 21
Creditors meeting called for Sublimity Therapeutics A creditors meeting has been called to consider a proposal to put Irish pharmaceutical company, Sublimity Therapeutics, into liquidation. Business • 13 Apr 21
MSD to takeover Takeda's Dunboyne facility Pharmaceutical firm MSD has agreed to acquire Takeda's manufacturing facility in Dunboyne, Co Meath as a going concern. Business • 07 Aug 20
Amryt Pharma forecasts strong revenue growth Dublin-headquartered pharmaceutical firm Amryt has reported an operating loss of $12m for the second quarter, despite a 22% rise in revenues in the period. Business • 06 Aug 20
Open Orphan raises £12m for Covid-19 testing Irish pharmaceutical firm Open Orphan has raised £12m, which it will put towards the hunt to find a vaccine for Covid-19. Business • 22 May 20
Uniphar's 2019 growth in line with expectations Uniphar says it achieved gross organic profit growth of 7% last year, in line with its expectations. Business • 04 Feb 20
320 jobs to go at Novartis in Cork A total of 320 jobs are to go at Novartis in Co Cork as it closes one of its production buildings by mid-2022. Ireland • 23 Oct 19
Trump pledge on pharma industry threatens Ireland US President-elect Donald Trump has said he will push the pharmaceutical industry to move production back to the USA, a potential threat to Ireland's biggest … Business • 11 Jan 17
US result boosts drug stocks as pricing fears ease Pharmaceutical stocks surged in Europe today as Republican Donald Trump's US presidential election win led investors to conclude the threat of tough action on drug … Business • 09 Nov 16
Pfizer's quarterly profit below expectations Pfizer has reported a quarterly adjusted profit that just missed analysts' estimates, while the company also shaved 4 cents off its 2016 earnings forecast after … Business • 01 Nov 16
Pharmaceutical firm plans 80 new jobs Pharmaceutical company Alter Pharma is to significantly increase its staffing in Ireland following the opening of its new worldwide headquarters in Dublin. Business • 23 Sep 16
Pfizer reports better-than-expected earnings in Q2 Pfizer has reported better-than-expected second-quarter earnings due to solid sales of several pharma products that offset the hit from the strong dollar. Business • 02 Aug 16
Icon sees strong income growth in first quarter Clinical research firm Icon has reported a jump in income during the first quarter, as revenue rose despite the impact of adverse currency movements. Business • 26 Apr 16
Shire goes public on $30bn bid for Baxalta Pharmaceutical group Shire said it was seeking to buy Baxalta in a $30 billion all-share deal, going public with its bid to create a global … Business • 04 Aug 15
Israel's Teva to buy Allergan for $40.5bn Israeli pharmaceutical giant Teva said that it was buying the generic drug business of Allergan for $40.5 billion, consolidating its position as a world leader … Business • 27 Jul 15
Parexel to create 130 jobs in Dublin Biopharmaceutical company Parexel is to create 130 jobs in Dublin over the next year and a half. Business • 27 Jul 15
Dublin-based Perrigo rejects Mylan's latest bid Generic drug company Mylan has raised its bid for a second time for Perrigo, offering $35.6 billion for the over-the-counter giant, but the offer has … Business • 29 Apr 15
Icon records 54.7% rise in pre-tax profit for Q1 Dublin-based firm Icon has reported a 54.7% rise in pre-tax profit in the first quarter of 2015 after a sharp rise in company revenue. Business • 28 Apr 15
Horizon Pharma set to buy Hyperion for $1.1bn Irish-based Horizon Pharma said it would buy US drugmaker Hyperion Therapeutics for about $1.1bn to add to its line-up of drugs that treat rare diseases. Business • 30 Mar 15
Pharma firms may be forced to cut drug costs The Minister for Health is considering using existing legislation to achieve savings in the cost of medicines, according to his spokesperson. News • 01 Feb 15
Roche to acquire InterMune in $8.3bn deal Roche Holding has agreed to buy US biotech company InterMune for $8.3bn in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. Business • 25 Aug 14
Sharp fall in industrial production during June Industrial production rose in June when compared with the same month of 2013, according to data from the Central Statistics Office, but was down sharply … Business • 07 Aug 14
Shire formally accepts AbbVie takeover offer Dublin-based Shire Pharmaceuticals has accepted a €40bn takeover bid from US giant AbbVie, the two companies have said. Business • 18 Jul 14
Teva pharmaceutical sees revenue grow in Q1 Pharmaceutical group Teva has reported revenues of $5bn for the first three months of 2014; up 2% on the same period of last year. Business • 01 May 14
Pfizer confirms takeover bid for AstraZeneca Pfizer is working on its next move in a potential $100 billion battle for Britain's AstraZeneca after having two bids rejected, as deal-making grips the … Business • 28 Apr 14
